Pharmallama: Financial Breakdown
Decoding financial health metrics of Pharmallama
- Total Expenses₹4.9 Lakh-98%
Prev. FY
- Profit After Tax₹-4.9 Lakh97%
Prev. FY
- Total Assets₹59.5 Lakh-8%
Prev. FY
FAQs on Financials of Pharmallama
No. In FY24, Pharmallama reported a net loss of ₹1.9 Cr, so it was not profitable.
Pharmallama's revenue declined 96.2% year-on-year, from ₹81.2 Lakh in FY23 to ₹3.1 Lakh in FY24.
In FY24, Pharmallama posted revenue of ₹3.1 Lakh (down 96.2% YoY) and a net loss of ₹1.9 Cr. Explore the full financials of Pharmallama here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links

